About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Unsuccessful Drug for Anxiety may Treat Cancer

by Rajashri on September 6, 2008 at 4:49 PM
Font : A-A+

 Unsuccessful Drug for Anxiety may Treat Cancer

Finnish and Danish researchers are reporting that Siramesine, an unsuccessful drug against anxiety, can act as a promising anti-cancer drug, targeting a novel molecule called phosphatidic acid.

Cancer cells have many ways to deal with apoptosis, programmed cell death the means by which organisms deal with defective cells. One such defense is to produce quantities of phosphatic acid, a phospholipid constituent of cellular membranes.

Advertisement

However, phosphatidic acid, unlike other phospholipids, also acts as a signaling molecule for cells promoting cellular growth and preventing apoptosis.

The researchers have now shown that phosphatidic acid may act as a target molecule for novel anti-cancer drugs.

Siramesine is a drug molecule developed and synthesized by Lundbeck A/S for the treatment of anxiety. Its development was discontinued due to unsatisfying efficacy in clinical trials in 2002.
Advertisement

Later professor Marja Jaattela and co-workers at the Danish cancer institute discovered that siramesine effectively inhibits the growth of both cultured cancer cells as well as solid tumors in mice.

Siramesine is known to bind sigma-receptors, the physiological role of which remains unknown, on the cellular surface and this interaction was also believed to underlie its anti-tumor actions.

Led by Professor Paavo Kinnunen, the researchers studied the interaction of this drug with different phospholipids using biophysical methods and different model cellular membranes.

Also, a computer simulation was performed as collaboration with MEMPHYS, Odense, Denmark, to further their understanding of this interaction.

"The key finding of our study was that siramesine avidly and specifically binds to phosphatidic acid", said MD Mikko Parry from Helsinki Biophysics and Biomembrane group at the Institute of Biomedicine, University of Helsinki.

He added: "Importantly, this is the first time it's shown that a lipid second messenger can act as a drug target: it is a totally new mechanism of action and constitutes a novel paradigm for developing new, more effective anti-cancer drugs."

Source: ANI
RAS/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Spirituality and Mental Health
Health Benefits of Sea Buckthorn
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Anxiety Disorder Agoraphobia Cancer and Homeopathy Aspergerīs Syndrome Signature Drug Toxicity Stress Relief Through Alternative Medicine Cancer Facts Cancer Hyperventilation 

Recommended Reading
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of ....
Biopsy-Introduction
Encyclopedia section of medindia explains in brief Introduction To Biopsy...
Agoraphobia
Agoraphobia is an anxiety disorder characterised by the patient avoiding spaces, crowds, or ......
Anxiety Disorder
Anxiety disorder involves excessive worry about actual circumstances, events or conflicts. Anyone ca...
Aspergerīs Syndrome
Asperger’s Syndrome or (AS) is a neurological condition marked by delay in the development of motor ...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Hyperventilation
Hyperventilation occurs when a person breathes in excess to the body’s requirement....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use